Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Mulitplicom's MID and MASTR Kits; Laboratoire Cerba's NIPT; More


Belgian company Multiplicom has launched a CE-IVD labeled MID kit for Illumina's MiSeq system as well as three germline mutation detection kits using the company's MASTR technology for maturity onset diabetes of the young, autosomal dominant hypercholesterolemia, and hypertrophic cardiomyopathy.

The MID kit is designed to be used with Multiplicom's MASTR assays, and each kit contains eight specific p7 MID Primers and six specific p5 MID Primers, enabling 48 possible p7-p5 MID combinations. It can be used for diagnostic purposes when combined with the CE-labeled MASTR Dx and MID Dx kits.

Laboratoire Cerba has launched its noninvasive prenatal test in France, Belgium, Luxembourg and parts of the Middle East and Africa. The test uses technology licensed from Sequenom to screen for fetal trisomies 21, 18, and 13.

Molecular diagnostic company Diagnovus has launched Engauge-cancer DLBCL Gene Panel, a next-gen sequencing-based panel for diffuse large B-cell lymphoma. The hotspot panel assesses 17 genes related to diffuse large B-cell lymphoma and has a turnaround time of seven to 10 days.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.